Enhabit Home Health & Hospice (NYSE: EHAB) has honed its sights on hospice growth, with substantial investments into staffing and acquisitions. Enhabit executives recently discussed what these investments mean for the future of its hospice business segment at the recent Wells Fargo Healthcare Conference in Boston. “Hospice has been more of a growing side of […]
Some hospice company leaders have signaled the labor market may be showing signs of stabilization. Executives from 13 publicly traded home-based care companies participated last week in Jeffries Financial Group’s annual Nashville Healthcare Services Burr Tour, including contingents from Addus (NASDAQ: ADUS), Amedisys (NASDAQ: AMED), CVS Health (NASDAQ: CVS), Signify Health (NASDAQ: SGNY), and Enhabit […]
A turbulent economy and slight cool-down in deal activity early in the year have led some to question whether the record-high valuations for hospice assets will start to tumble. Like most business sectors, health care has felt the aftershocks of global economic trends such as rising inflation, supply chain disruption, and the continued effects of […]
Disruption in home health reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. The most recent example is the 2020 implementation of the Patient-driven Groupings Model (PDGM). Uncertain about how this new payment system would impact their businesses, a number of strategic buyers […]
Barbara Jacobsmeyer as of July 1 became the first CEO of Enhabit Home Health and Hospice (NYSE: EHAB) as an independent, standalone company. Enhabit emerged from the spinoff of Encompass Health’s (NYSE: EHC) home health and hospice segment, which completed in July. The new company expects to earn nearly $1.08 billion to $1.12 billion this […]
Enhabit Home Health & Hospice (NYSE: EHAB) is running against the wind right out of the gates due to labor and capacity constraints — but remains poised for hospice acquisitions as the rest of this year unfolds. Enhabit completed its split from Encompass Health (NYSE: EHC) last month, becoming its own separate, publicly traded company […]
Hospice acquisition volumes and price tags have hit record highs for several years running. Now, the companies that performed well under the pandemic’s pressure may be drawing more interest from buyers. While a sizzling hospice market saw a cooled start this year, merger and acquisition activity is still outpacing other health care sectors. Demographic tailwinds, […]
More hospice and palliative care providers are pursuing joint ventures with hospitals and health systems. Joint ventures offer unique advantages compared to traditional referral streams, according to Aaron Stein, COO of Contessa Health, a subsidiary of Amedisys (NASDAQ: AMED). Joint ventures allow providers to develop integrated care models that build improved transitions of care, said […]
Encompass Health (NYSE: EHC) has completed its spin-off of Enhabit Home Health & Hospice (NYSE: EHAB), which as of today is a separate, publicly traded company on the New York Stock Exchange (NYSE). Encompass announced the strategic repositioning of its home health and hospice segment in December 2020. The new company expects to earn nearly […]
As one massive home health and hospice transaction steams towards completion, another is delayed. The forthcoming spin-off of Enhabit Home Health & Hospice from Encompass Health (NYSE: EHC) is just about ready to close on July 1. Meanwhile, a minor administrative snag will delay closing of UnitedHealth Group (NYSE: UHG) subsidiary Optum’s acquisition of LHC […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
